Curis | CRIS - Gewinn Vor Steuern





Gewinn Vor Steuern Veränderung Datum
Alaunos Therapeutics USD -7.84M 633K 2023-12
Amgen USD 1.51B 2.41B 2025-12
AstraZeneca USD 3.91B 1.28B 2026-03
Bayer EUR -3.37B 2.21B 2025-12
Bristol-Myers Squibb USD 1.47B 1.64B 2025-12
CSL USD 2.61B 1.21B 2025-12
Curis USD 19.36M 33.34M 2025-12
Eli Lilly USD 8.27B 1.03B 2025-12
Exelixis USD 267.69M 15M 2026-03
Gilead Sciences USD 2.08B 1.56B 2025-12
GlaxoSmithKline GBP 2.14B 919M 2026-03
Incyte USD 343.6M 46.34M 2026-03
Merck USD 3.42B 3.32B 2025-12
Novartis USD 3.84B 802M 2026-03
Pfizer USD 5.18B 6.82B 2026-03
Roche Holding CHF 4.79B 3.01B 2025-06
Sanofi EUR -1.16B 5.5B 2025-12
Takeda JPY -52.48B 186.34B 2026-03
TG Therapeutics USD 20.36M 24.73M 2026-03
Verastem USD -32.92M 944K 2025-12
Xoma USD 15.98M 24.58M 2024-06